AK Medical Holdings
Market Cap
HK$23.7b
Last Updated
2020/08/08 12:34 UTC
Data Sources
Company Financials +
Executive Summary
AK Medical Holdings Limited, an investment holding company, designs, develops, produces, and markets orthopedic joint implants and related products under the AK Medical brand in China and internationally.
Rewards
Risk Analysis
Snowflake Analysis
Exceptional growth potential with solid track record.
Similar Companies
Share Price & News
How has AK Medical Holdings's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 1789's share price has been volatile over the past 3 months.
Market Performance
7 Day Return
-6.0%
1789
4.0%
HK Medical Equipment
1.2%
HK Market
1 Year Return
352.2%
1789
227.7%
HK Medical Equipment
5.5%
HK Market
Return vs Industry: 1789 exceeded the Hong Kong Medical Equipment industry which returned 227.7% over the past year.
Return vs Market: 1789 exceeded the Hong Kong Market which returned 5.5% over the past year.
Shareholder returns
| 1789 | Industry | Market | |
|---|---|---|---|
| 7 Day | -6.0% | 4.0% | 1.2% |
| 30 Day | -21.0% | -3.7% | -3.8% |
| 90 Day | -2.1% | 52.2% | 7.7% |
| 1 Year | 353.8%352.2% | 229.8%227.7% | 9.8%5.5% |
| 3 Year | n/a | 212.4%203.8% | 3.7%-7.4% |
| 5 Year | n/a | 307.4%288.3% | 12.3%-6.5% |
Price Volatility Vs. Market
How volatile is AK Medical Holdings's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 days ago | Simply Wall St
Here's Why I Think AK Medical Holdings (HKG:1789) Might Deserve Your Attention Today2 weeks ago | Simply Wall St
What You Need To Know About AK Medical Holdings Limited's (HKG:1789) Investor Composition1 month ago | Simply Wall St
Who Has Been Selling AK Medical Holdings Limited (HKG:1789) Shares?Valuation
Is AK Medical Holdings undervalued compared to its fair value and its price relative to the market?
74.71x
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: 1789 (HK$21.3) is trading above our estimate of fair value (HK$15.42)
Significantly Below Fair Value: 1789 is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: 1789 is poor value based on its PE Ratio (74.7x) compared to the HK Medical Equipment industry average (51.1x).
PE vs Market: 1789 is poor value based on its PE Ratio (74.7x) compared to the Hong Kong market (10.3x).
Price to Earnings Growth Ratio
PEG Ratio: 1789 is poor value based on its PEG Ratio (2.3x)
Price to Book Ratio
PB vs Industry: 1789 is overvalued based on its PB Ratio (18.1x) compared to the HK Medical Equipment industry average (4.2x).
Next Steps
Future Growth
How is AK Medical Holdings forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?
32.0%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 1789's forecast earnings growth (32% per year) is above the savings rate (1.6%).
Earnings vs Market: 1789's earnings (32% per year) are forecast to grow faster than the Hong Kong market (18.7% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 1789's revenue (26.3% per year) is forecast to grow faster than the Hong Kong market (11.4% per year).
High Growth Revenue: 1789's revenue (26.3% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 1789's Return on Equity is forecast to be high in 3 years time (28.1%)
Next Steps
Past Performance
How has AK Medical Holdings performed over the past 5 years?
30.6%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 1789 has a high level of non-cash earnings.
Growing Profit Margin: 1789's current net profit margins (28.8%) are higher than last year (24.1%).
Past Earnings Growth Analysis
Earnings Trend: 1789's earnings have grown significantly by 30.6% per year over the past 5 years.
Accelerating Growth: 1789's earnings growth over the past year (84.2%) exceeds its 5-year average (30.6% per year).
Earnings vs Industry: 1789 earnings growth over the past year (84.2%) exceeded the Medical Equipment industry 16%.
Return on Equity
High ROE: 1789's Return on Equity (23.9%) is considered high.
Next Steps
Financial Health
How is AK Medical Holdings's financial position?
Financial Position Analysis
Short Term Liabilities: 1789's short term assets (CN¥1.1B) exceed its short term liabilities (CN¥327.9M).
Long Term Liabilities: 1789's short term assets (CN¥1.1B) exceed its long term liabilities (CN¥38.3M).
Debt to Equity History and Analysis
Debt Level: 1789's debt to equity ratio (0.2%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if 1789's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: 1789's debt is well covered by operating cash flow (8509.5%).
Interest Coverage: 1789 earns more interest than it pays, so coverage of interest payments is not a concern.
Balance Sheet
Next Steps
Dividend
What is AK Medical Holdings's current dividend yield, its reliability and sustainability?
0.35%
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: 1789's dividend (0.35%) isn’t notable compared to the bottom 25% of dividend payers in the Hong Kong market (2.29%).
High Dividend: 1789's dividend (0.35%) is low compared to the top 25% of dividend payers in the Hong Kong market (6.87%).
Stability and Growth of Payments
Stable Dividend: 1789 is not paying a notable dividend for the Hong Kong market, therefore no need to check if payments are stable.
Growing Dividend: 1789 is not paying a notable dividend for the Hong Kong market, therefore no need to check if payments are increasing.
Current Payout to Shareholders
Dividend Coverage: 1789 is not paying a notable dividend for the Hong Kong market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of 1789's dividend in 3 years as they are not forecast to pay a notable one for the Hong Kong market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
4.3yrs
Average management tenure
CEO
Zhijiang Li (52 yo)
no data
Tenure
CN¥1,490,000
Compensation
Mr. Zhijiang Li serves as Chairman and Chief Executive Officer at AK Medical Holdings Limited. Mr. Li is responsible for the overall strategic planning and development of at AK Medical Holdings Limited. Mr ...
CEO Compensation Analysis
Compensation vs Market: Zhijiang's total compensation ($USD213.84K) is below average for companies of similar size in the Hong Kong market ($USD498.20K).
Compensation vs Earnings: Zhijiang's compensation has been consistent with company performance over the past year.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | no data | CN¥1.49m | 45.35% CN¥ 10.8b | |
| CFO & Executive Director | 4.5yrs | CN¥2.52m | 0.090% CN¥ 21.3m | |
| Senior VP & Executive Director | 5.08yrs | CN¥306.00k | 0.91% CN¥ 215.7m | |
| Senior VP & Executive Director | 5.08yrs | CN¥1.12m | 5.28% CN¥ 1.3b | |
| Chief Engineer of Ak Medical Beijing | 11.67yrs | no data | no data | |
| Head of Production Centre of AK Medical Beijing | 3.67yrs | no data | no data | |
| Joint Company Secretary | 4.33yrs | no data | no data | |
| Joint Company Secretary | 4.33yrs | no data | no data |
4.3yrs
Average Tenure
51.5yo
Average Age
Experienced Management: 1789's management team is considered experienced (4.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | no data | CN¥1.49m | 45.35% CN¥ 10.8b | |
| CFO & Executive Director | 4.5yrs | CN¥2.52m | 0.090% CN¥ 21.3m | |
| Senior VP & Executive Director | 5.08yrs | CN¥306.00k | 0.91% CN¥ 215.7m | |
| Senior VP & Executive Director | 5.08yrs | CN¥1.12m | 5.28% CN¥ 1.3b | |
| Non-Executive Director | 4.5yrs | no data | no data | |
| Independent Non-Executive Director | 2.75yrs | CN¥158.00k | no data | |
| Independent Non-Executive Director | 0.17yr | no data | no data | |
| Independent Non-Executive Director | 2.75yrs | CN¥158.00k | no data |
4.4yrs
Average Tenure
52yo
Average Age
Experienced Board: 1789's board of directors are considered experienced (4.4 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 6.7%.
Top Shareholders
Company Information
AK Medical Holdings Limited's company bio, employee growth, exchange listings and data sources
Key Information
- Name: AK Medical Holdings Limited
- Ticker: 1789
- Exchange: SEHK
- Founded: 2003
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: HK$23.728b
- Shares outstanding: 1.11b
- Website: https://www.ak-medical.net
Number of Employees
Location
- AK Medical Holdings Limited
- Xingye Building
- 2nd Floor
- Beijing
- Beijing Province
- 102200
- China
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| 1789 | SEHK (The Stock Exchange of Hong Kong Ltd.) | Yes | Ordinary Shares | HK | HKD | Dec 2017 |
Biography
AK Medical Holdings Limited, an investment holding company, designs, develops, produces, and markets orthopedic joint implants and related products under the AK Medical brand in China and internationally. ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2020/08/08 12:34 |
| End of Day Share Price | 2020/08/07 00:00 |
| Earnings | 2019/12/31 |
| Annual Earnings | 2019/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.